Physician profile
Deepa Bhanot
NPI 1184936890
$1,193.73
in general payments reported to CMS, 2019-2025
20 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $314 · 2021: $72.61 · 2022: $19.83 · 2024: $84.12 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $323.16 | 2020-2025 | Trelegy Ellipta |
| Sunovion Pharmaceuticals INC. | $169.47 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.18 | 2019-2022 | |
| Genzyme Corporation | $80.49 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $55.65 | 2019-2020 | |
| Genentech USA, INC. | $54.35 | 2019-2020 | |
| Shire North American Group INC | $51.14 | 2019 | |
| Philips North America LLC | $49.43 | 2019 | |
| Insmed, INC. | $46.85 | 2019-2025 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $36.52 | 2020 | |
| Mylan Specialty L.P. | $36.25 | 2019-2021 | |
| Grifols USA, LLC | $32.60 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $27.55 | 2019 | |
| Amgen INC. | $23.03 | 2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $21.76 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $20.27 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.62 | 2019 | |
| Resmed Corp | $16.61 | 2019 | |
| Jazz Pharmaceuticals INC. | $13.70 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepa Bhanot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.